Atossa Therapeutics, Inc. (ATOS)
5.34
+0.01
(+0.19%)
USD |
NASDAQ |
Feb 06, 16:00
5.35
+0.01
(+0.19%)
After-Hours: 20:00
Atossa Therapeutics EPS Diluted (Quarterly) : -1.009 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.009 |
| Plus Therapeutics, Inc. | -0.0412 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
| Kiora Pharmaceuticals, Inc. | 0.0062 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.692M |
| Total Expenses (Quarterly) | 8.692M |
| Enterprise Value | -5.970M |
| Earnings Yield | -52.28% |
| Normalized Earnings Yield | -52.27 |